Charles H. Cummings, D.O.

Family Medicine • Tiverton, RI

Home/Tiverton/Family Medicine/Charles H. Cummings, D.O.

About

Office of Charles H. Cummings, D.O. is a family medicine clinic located in Tiverton, Rhode Island. The practice offers family internal medicine, osteopathic manipulative medicine, and pulmonary medicine services. It is part of Prima CARE, a healthcare network operating across Massachusetts and Rhode Island.

Call clinic Visit website Get directions

Clinic Type

Family Medicine

Address

Office of Charles H. Cummings, Tiverton, RI 02878

Phone

((40) 1) -625-1001

Email

—

Opening Hours

Not published — contact the clinic to confirm hours.

Website

https://www.prima-care.com/location/office-of-charles-h-cummings-do-tiverton-02878-ri

Services Offered

Family Internal Medicine
Osteopathic Manipulative Medicine
Pulmonary Medicine

Team

Charles H. Cummings — Physician

Insurance & Payment

—

Languages Spoken

—

Social Media

Twitter Facebook Linkedin Instagram

Photos

What Patients Say

Overall sentiment across review platforms: positive

DocSpot: 4.43 out of 5 stars (7 ratings)
US News Health: 5 out of 5 stars (18 reviews)

Patients praise

Dedicated and knowledgeable care
Takes time to listen to patients
Compassionate and nonjudgmental approach to holistic care
Friendly and efficient office staff
Flexible scheduling and willingness to accommodate patient needs

Common complaints

No specific complaints mentioned in available reviews; reviews are overwhelmingly positive

"Dr Cummings has gone above and beyond the “normal pcp” level of care we are accustomed to. His staff is friendly, efficient and it’s easy to get an appt with him. He takes the time to listen to his patients and he is just a genuinely good doctor."

— LocalityBiz review by Jk J

"Dr. Cummings is a rare physician who takes care of the whole person….. head to toe ….physically and emotionally. He knows his patients…. Taking the time to build a relationship with them..."

— LocalityBiz review by Clara Reagan

Synthesized from public review platforms as of Jul 11, 2026 — sources: [1][2][3][4].